Vimarsana
Biggest News Aggregation in the World

Wang Xiaochun News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Wang Xiaochun. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Wang Xiaochun Today - Breaking & Trending Today

Certain A Shares of Western Regions Tourism Development Co.,Ltd are subject to a Lock-Up Agreement Ending on 6-AUG-2023. - Vimarsana News

Certain A Shares of Western Regions Tourism Development Co.,Ltd are subject to a Lock-Up Agreement Ending on 6-AUG-2023.

Certain A Shares of Western Regions Tourism Development Co.,Ltd are subject to a Lock-Up Agreement Ending on 6-AUG-2023. These A Shares will be under lockup for 1103 days starting from 29-JUL-2020 to...

Sinopharm Led Consortium Plans 3 3 Billion Take Private Of HK Listed China TCM - Vimarsana News

Sinopharm Led Consortium Plans 3 3 Billion Take Private Of HK Listed China TCM

BW Businessworld Sinopharm-Led Consortium Plans $3.3 Billion Take-Private Of HK-Listed China TCM The total value of buyouts of Hong Kong-listed companies reached $25 billion last year, up 190% from 2019 and the highest since 2017. The number of such transactions - at 60 - is already an annual record, Photo Credit : A consortium led by state-owned pharma giant Sinopharm plans to take private China Traditional Chinese Medicine Holdings in a deal that would value the firm at at least $3.3 billion, said two people with direct knowledge of the matter. Sinopharm, China TCM's parent and major share...

Exclusive: Sinopharm-led consortium plans $3.3 billion take-private of HK-listed China TCM - sources - Vimarsana News

Exclusive: Sinopharm-led consortium plans $3.3 billion take-private of HK-listed China TCM - sources

* Represents 33% premium to 1-month average price - sources * Consortium seeks to finalize deal by end-March - sources * 2020 HK-listed take-private deals rose to $25 bln - Refinitiv HONG KONG, Jan 27 (Reuters) - A consortium led by state-owned pharma giant Sinopharm plans to take private China Traditional Chinese Medicine Holdings in a deal that would value the firm at at least $3.3 billion, said two people with direct knowledge of the matter. Sinopharm, China TCM’s parent and major shareholder, is teaming up with the next two biggest stockholders, Ping An Insurance Group Co of China and e...

Exclusive: Sinopharm-led consortium plans US$3.3 billion take-private of HK-listed China TCM - sources - Vimarsana News

Exclusive: Sinopharm-led consortium plans US$3.3 billion take-private of HK-listed China TCM - sources

Exclusive: Sinopharm-led consortium plans US$3.3 billion take-private of HK-listed China TCM - sources Toggle share menu Advertisement Exclusive: Sinopharm-led consortium plans US$3.3 billion take-private of HK-listed China TCM - sources A consortium led by state-owned pharma giant Sinopharm plans to take private China Traditional Chinese Medicine Holdings in a deal that would value the firm at at least US$3.3 billion, said two people with direct knowledge of the matter. FILE PHOTO: A sign of Sinopharm is seen at the 2020 China International Fai...

Exclusive: Sinopharm-led consortium plans $3.3 billion take-private of HK-listed China TCM – sources - Vimarsana News

Exclusive: Sinopharm-led consortium plans $3.3 billion take-private of HK-listed China TCM – sources

By Julie Zhu and Kane Wu HONG KONG (Reuters) - A consortium led by state-owned pharma giant Sinopharm plans to take private China Traditional Chinese ...

Source: wsau.com